Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates
Clinical trial NCT03536117 · COMPLETED
Trial details
- NCT number
- NCT03536117
- Sponsor
- Biofabri, S.L
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-12
- Primary completion
- 2022-05-17
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.